Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The degree of tumor volume reduction during the early phase of induction chemotherapy is an independent prognostic factor in patients with high-risk neuroblastoma.

Yoo SY, Kim JS, Sung KW, Jeon TY, Choi JY, Moon SH, Son MH, Lee SH, Yoo KH, Koo HH.

Cancer. 2013 Feb 1;119(3):656-64. doi: 10.1002/cncr.27775. Epub 2012 Sep 5.

2.

Role of surgery in the treatment of patients with high-risk neuroblastoma who have a poor response to induction chemotherapy.

Du L, Liu L, Zhang C, Cai W, Wu Y, Wang J, Lv F.

J Pediatr Surg. 2014 Apr;49(4):528-33. doi: 10.1016/j.jpedsurg.2013.11.061. Epub 2013 Dec 1.

PMID:
24726106
3.

Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.

Ladenstein R, Philip T, Lasset C, Hartmann O, Garaventa A, Pinkerton R, Michon J, Pritchard J, Klingebiel T, Kremens B, Pearson A, Coze C, Paolucci P, Frappaz D, Gadner H, Chauvin F.

J Clin Oncol. 1998 Mar;16(3):953-65.

PMID:
9508178
4.

[Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].

Ladenstein R, Ambros PF, Urban C, Ambros IM, Fink FM, Zoubek A, Grienberger H, Schmitt K, Kerbl R, Horcher E, Amann G, Höfler G, Heinzl H, Gadner H, Mutz I.

Klin Padiatr. 1996 Jul-Aug;208(4):210-20. German.

PMID:
8926686
5.

N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.

Rubie H, Hartmann O, Michon J, Frappaz D, Coze C, Chastagner P, Baranzelli MC, Plantaz D, Avet-Loiseau H, Bénard J, Delattre O, Favrot M, Peyroulet MC, Thyss A, Perel Y, Bergeron C, Courbon-Collet B, Vannier JP, Lemerle J, Sommelet D.

J Clin Oncol. 1997 Mar;15(3):1171-82.

PMID:
9060561
6.

Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow Transplantation.

Ladenstein R, Lasset C, Hartmann O, Frappaz D, Garaventa A, Klingebiel T, Zucker JM, Coze C, Burdach S, Gadner H, et al.

J Clin Oncol. 1993 Dec;11(12):2330-41.

PMID:
8246022
7.

Outcome of high-risk neuroblastoma using a dose intensity approach: improvement in initial but not in long-term results.

Castel V, Cañete A, Navarro S, García-Miguel P, Melero C, Acha T, Navajas A, Badal MD.

Med Pediatr Oncol. 2001 Dec;37(6):537-42.

PMID:
11745893
8.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
9.

Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors.

Garaventa A, Boni L, Lo Piccolo MS, Tonini GP, Gambini C, Mancini A, Tonegatti L, Carli M, di Montezemolo LC, Di Cataldo A, Casale F, Mazzocco K, Cecchetto G, Rizzo A, Bernardi B; Italian Cooperative Group for Neuroblastoma.

Ann Oncol. 2002 Jun;13(6):956-64.

10.

Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma.

De Bernardi B, Nicolas B, Boni L, Indolfi P, Carli M, Cordero Di Montezemolo L, Donfrancesco A, Pession A, Provenzi M, di Cataldo A, Rizzo A, Tonini GP, Dallorso S, Conte M, Gambini C, Garaventa A, Bonetti F, Zanazzo A, D'Angelo P, Bruzzi P; Italian Co-Operative Group for Neuroblastoma.

J Clin Oncol. 2003 Apr 15;21(8):1592-601.

PMID:
12697885
11.

Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification.

Kaneko M, Tsuchida Y, Mugishima H, Ohnuma N, Yamamoto K, Kawa K, Iwafuchi M, Sawada T, Suita S.

J Pediatr Hematol Oncol. 2002 Nov;24(8):613-21.

PMID:
12439032
12.

Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for Neuroblastoma.

Garaventa A, De Bernardi B, Pianca C, Donfrancesco A, Cordero di Montezemolo L, Di Tullio MT, Bagnulo S, Mancini A, Carli M, Pession A, et al.

J Clin Oncol. 1993 Sep;11(9):1770-9.

PMID:
8355044
13.
14.

Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.

Bowman LC, Castleberry RP, Cantor A, Joshi V, Cohn SL, Smith EI, Yu A, Brodeur GM, Hayes FA, Look AT.

J Natl Cancer Inst. 1997 Mar 5;89(5):373-80.

15.

Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.

Kim MS, Lee SY, Cho WH, Song WS, Koh JS, Lee JA, Yoo JY, Jeon DG.

Ann Surg Oncol. 2008 Mar;15(3):906-14. Epub 2007 Dec 28.

PMID:
18163171
16.

Tumor histology during induction therapy in patients with high-risk neuroblastoma.

George RE, Perez-Atayde AR, Yao X, London WB, Shamberger RC, Neuberg D, Diller L.

Pediatr Blood Cancer. 2012 Sep;59(3):506-10. doi: 10.1002/pbc.24013. Epub 2011 Dec 11.

PMID:
22162143
17.

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP.

N Engl J Med. 1999 Oct 14;341(16):1165-73.

18.

Neuroblastoma.

Meir HM, Balawi I, Nayel H, Yousef MK, Badawood S, Al-Mobarak M.

Saudi Med J. 2001 Aug;22(8):674-80.

PMID:
11573111
19.

Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era.

Kushner BH, Modak S, Kramer K, LaQuaglia MP, Yataghene K, Basu EM, Roberts SS, Cheung NK.

Cancer. 2014 Jul 1;120(13):2050-9. doi: 10.1002/cncr.28687. Epub 2014 Apr 1.

20.

[The prognostic significance of tumor volume in osteosarcoma with neoadjuvant chemotherapy].

Rehan N, Bieling P, Winkler P, Helmke K, Maas R, Baldini N, Heise U, Fuchs N, Winkler K.

Klin Padiatr. 1993 Jul-Aug;205(4):200-9. German.

PMID:
8377444
Items per page

Supplemental Content

Write to the Help Desk